品牌阿托伐他汀在仿制药阿托伐他汀推出后的使用和支出趋势。
Trends in Use and Expenditures of Brand-name Atorvastatin After Introduction of Generic Atorvastatin.
机构信息
Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Center for Healthcare Advancement and Outcomes, Baptist Health South Florida, Miami.
出版信息
JAMA Intern Med. 2018 May 1;178(5):719-721. doi: 10.1001/jamainternmed.2018.0990.
Abstract
This study uses the Medical Expenditure Panel Survey (MEPS) database to analyze trends in use and expenditures of brand-name atorvastin after generic atorvastatin became available.
摘要
本研究使用医疗支出面板调查（MEPS）数据库，分析了在通用阿托伐他汀上市后，品牌阿托伐他汀的使用和支出趋势。
相似文献
1
Trends in Use and Expenditures of Brand-name Atorvastatin After Introduction of Generic Atorvastatin.
JAMA Intern Med. 2018 May 1;178(5):719-721. doi: 10.1001/jamainternmed.2018.0990.
2
Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
JAMA Intern Med. 2016 Sep 1;176(9):1317-23. doi: 10.1001/jamainternmed.2016.3384.
3
Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018.
JAMA Netw Open. 2021 Nov 1;4(11):e2135371. doi: 10.1001/jamanetworkopen.2021.35371.
4
[Comparison of compliance and cost effectiveness between brand-name statins and generic statins].
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Nov 10;41(11):1900-1904. doi: 10.3760/cma.j.cn112338-20191114-00809.
5
Twenty-Year Nationwide Trends in Statin Utilization and Expenditure in Denmark.
Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7). doi: 10.1161/CIRCOUTCOMES.117.003811.
6
Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
JAMA Intern Med. 2016 Jun 1;176(6):763-8. doi: 10.1001/jamainternmed.2016.1709.
7
Generic atorvastatin and health care costs.
N Engl J Med. 2012 Jan 19;366(3):201-4. doi: 10.1056/NEJMp1113112. Epub 2011 Dec 7.
8
Zero copayment for generic statins could save billions.
Manag Care. 2013 Mar;22(3):44.
9
Encouraging generic use can yield significant savings.
Find Brief. 2012 Nov;15(8):1-3.
10
The impact of manufacturer coupon use in the statin market.
J Manag Care Pharm. 2013 Nov-Dec;19(9):765-72. doi: 10.18553/jmcp.2013.19.9.765.
引用本文的文献
1
Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelines.
Saudi Pharm J. 2023 Jun;31(6):795-800. doi: 10.1016/j.jsps.2023.04.002. Epub 2023 Apr 11.
2
The long-term effect of generic price competition on the Hungarian statin market.
BMC Health Serv Res. 2023 May 6;23(1):447. doi: 10.1186/s12913-023-09431-6.
3
Health informatics interventions to minimize out-of-pocket medication costs for patients: what providers want.
JAMIA Open. 2022 Feb 24;5(1):ooac007. doi: 10.1093/jamiaopen/ooac007. eCollection 2022 Apr.
4
Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.
JAMA Intern Med. 2022 Feb 1;182(2):185-195. doi: 10.1001/jamainternmed.2021.7457.
5
Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018.
JAMA Netw Open. 2021 Nov 1;4(11):e2135371. doi: 10.1001/jamanetworkopen.2021.35371.
6
Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management?
Folia Microbiol (Praha). 2021 Dec;66(6):897-916. doi: 10.1007/s12223-021-00926-5. Epub 2021 Oct 26.
7
Ophthalmic Medication Expenditures and Out-of-Pocket Spending: An Analysis of United States Prescriptions from 2007 through 2016.
Ophthalmology. 2020 Oct;127(10):1292-1302. doi: 10.1016/j.ophtha.2020.04.037. Epub 2020 Apr 28.
8
Public knowledge, perception, and experience with generic medications in Saudi Arabia.
Saudi Med J. 2020 Apr;41(4):413-420. doi: 10.15537/smj.2020.4.24992.
9
Generic Drugs in the United States: Policies to Address Pricing and Competition.
Clin Pharmacol Ther. 2019 Feb;105(2):329-337. doi: 10.1002/cpt.1314. Epub 2019 Jan 10.
本文引用的文献
1
Medicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015.
JAMA Intern Med. 2018 Apr 1;178(4):567-569. doi: 10.1001/jamainternmed.2017.8016.
2
National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey.
JAMA Cardiol. 2017 Jan 1;2(1):56-65. doi: 10.1001/jamacardio.2016.4700.
3
Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
JAMA Intern Med. 2016 Sep 1;176(9):1317-23. doi: 10.1001/jamainternmed.2016.3384.
4
Estimation of Potential Savings Through Therapeutic Substitution.
JAMA Intern Med. 2016 Jun 1;176(6):769-75. doi: 10.1001/jamainternmed.2016.1704.
Zotero 插件